Our multidisciplinary team focuses on infectious diseases. We work to identify methods and strategies that facilitate the uptake of evidence-based interventions to improve well-being.
Our group uses implementation science approaches to help prevent, control and eliminate viral hepatitis, HIV and coronavirus (COVID-19) in Australia and globally. We work with key populations including people who inject drugs, young people, migrant populations, men who have sex with men, and Aboriginal and Torres Strait Islander Peoples.
Using an implementation science approach, our multidisciplinary team aims to improve population health. We do this by addressing social determinants, including contributing to the global elimination of viral hepatitis and HIV and controlling COVID-19.
Examples of our work include designing and evaluating health interventions to:
reduce the transmission and impact of blood borne viruses and COVID-19 infections
identify ways to limit the negative consequences of COVID-19-related public health restrictions.
We generate ‘real world’ evidence on what works. We also partner with policymakers, health practitioners and affected communities to ensure the timely translation of research evidence into:
impactful, innovative evidence-based public health policy and practice
health systems change.
We use mixed methodologies and participatory approaches in our work, including:
co-designing evidence-based interventions
training and capacity building
qualitative and quantitative research methods
designing and planning for implementation at-scale
health system strengthening
evidence informed policy and practice development
impact measurement, evaluation and cost-effectiveness.
Partnering to eliminate hepatitis C as a public health threat by 2030.
We’re working closely with staff and artists at The Torch, a not-for-profit First Nations-led arts organisation, to improve program engagement and effectiveness.
We're identifying innovative models of care so that no-one misses out on HCV care in Australia and globally.
This project addresses critical knowledge gaps in Australian and global efforts to eliminate hepatitis C as a public health threat by 2030.
This project aims to find out how Victorians are experiencing COVID-19 and responding to the measures introduced to stop the spread of the virus.
A partnership aimed at increasing hepatitis C treatment uptake among people who inject drugs (PWID) using nurse-led models of care in community and prison settings.
Burnet Institute is a key partner in a new global harm reduction program aiming to reduce the impact of hepatitis C among at-risk groups thanks to funding from global health agency Unitaid.
This website describes a co-designed intervention to reduce stigma in healthcare that is being trialled in services in Victoria and NSW in 2025-26
A short film co-created with Pasifika young people in the southeast of Melbourne about challenges they face at school.
This handbook aims to help service providers with creating community-led public health communications. It includes templates, guidance and examples around how to research and identify community needs; hosting a community forum; and developing and sharing health messages.
A guide to developing community-led public health communicationsDescribes the key outcomes of the CT2 Study which explored the impact of a simplified hepatitis C model of care in Myanmar.
Summary-Report_Hep_C_Myanmar_DigitalFinal.pdf [PDF 180.2 kB]We collaborated on the It’s Your Right Campaign, developed to promote hepatitis C testing and treatment to people who inject drugs.
Every year, Burnet and Kirby Institutes prepare a national report with the latest hepatitis C data across Australia.